Stockscreener 앱 받기
8.155
1.80%
-0.165
전일 마감가:
$8.32
열려 있는:
$8.17
하루 거래량:
5,139
Relative Volume:
0.05
시가총액:
$218.19M
수익:
$21.25M
순이익/손실:
$-16.05M
주가수익비율:
-13.37
EPS:
-0.61
순현금흐름:
$-17.14M
1주 성능:
-3.08%
1개월 성능:
+26.08%
6개월 성능:
+35.04%
1년 성능:
+18.75%
1일 변동 폭
$8.0617
$8.275
1주일 범위
$7.88
$8.49
52주 변동 폭
$3.96
$8.72
Fennec Pharmaceuticals Inc Stock (FENC) Company Profile
명칭
Fennec Pharmaceuticals Inc
전화
(919) 636-4530
주소
PO BOX 13628, RESEARCH TRIANGLE PARK, NC
FENC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
FENC
Fennec Pharmaceuticals Inc
|
8.16 | 218.19M | 21.25M | -16.05M | -17.14M | -0.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.76 | 113.97B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
524.26 | 52.15B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
306.71 | 40.16B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
581.50 | 35.45B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
271.77 | 27.80B | 3.81B | -644.79M | -669.77M | -6.24 |
Fennec Pharmaceuticals Inc Stock (FENC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-11-22 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2022-09-07 | 개시 | CapitalOne | Overweight |
| 2022-08-08 | 재개 | Craig Hallum | Buy |
| 2020-06-05 | 개시 | Cantor Fitzgerald | Overweight |
| 2018-10-11 | 개시 | Goldman | Buy |
Fennec Pharmaceuticals Inc 주식(FENC)의 최신 뉴스
(FENC) Investment Analysis and Advice - news.stocktradersdaily.com
Insider Sell: Rosty Raykov Sells 10,000 Shares of Fennec Pharmaceuticals Inc (FENC) - GuruFocus
Fennec Pharmaceuticals elects board members, shareholders approve proposals By Investing.com - Investing.com South Africa
Fennec Pharmaceuticals elects board members, shareholders approve proposals - Investing.com
Fennec Pharmaceuticals Approves Proposals at Shareholder Meeting - TipRanks
Fennec Announces Results of Annual Meeting - TradingView
Northern Trust Corp Sells 2,976 Shares of Fennec Pharmaceuticals Inc (NASDAQ:FENC) - Defense World
FENC Meeting Scheduled in Toronto Hosted by Craig-Hallum | FENC Stock News - GuruFocus
How To Trade (FENC) - news.stocktradersdaily.com
Indian Pharma Co. Hit With Patent Suit Over Fennec's Cancer Drug - Law360
Fennec Pharmaceuticals Inc (NASDAQ:FENC) Shares Acquired by BNP Paribas Financial Markets - Defense World
Fennec Pharmaceuticals (NASDAQ:FENC) versus Tarsus Pharmaceuticals (NASDAQ:TARS) Head-To-Head Comparison - Defense World
Q2 EPS Estimate for Fennec Pharmaceuticals Raised by Analyst - Defense World
HC Wainwright Brokers Increase Earnings Estimates for FENC - Defense World
FY2026 Earnings Estimate for TSE:FRX Issued By HC Wainwright - Defense World
Research Analysts Offer Predictions for FENC FY2026 Earnings - Defense World
Fennec Pharmaceuticals (NASDAQ:FENC) Earns Buy Rating from HC Wainwright - Defense World
Don't Ignore The Insider Selling In Fennec Pharmaceuticals - simplywall.st
Fennec Pharmaceuticals (TSE:FRX) Reaches New 12-Month High on Insider Buying Activity - Defense World
Fennec Pharmaceuticals at BioConnect: Strategic Moves and Market Expansion By Investing.com - Investing.com Canada
FENC: HC Wainwright Maintains "Buy" Rating and Price Target | FENC Stock News - GuruFocus
Fennec Pharma stock soars to 52-week high of $7.66 - Investing.com Australia
Insider Buying: Jeffrey Hackman Acquires 15,000 Shares of Fennec Pharmaceuticals Inc (FENC) - GuruFocus
Fennec Pharma stock soars to 52-week high of $7.66 By Investing.com - Investing.com India
(FENC) Long Term Investment Analysis - news.stocktradersdaily.com
Wedbush Forecasts Higher Earnings for Fennec Pharmaceuticals - Defense World
Wedbush Raises Earnings Estimates for Fennec Pharmaceuticals - Defense World
Fennec Pharmaceuticals’ Earnings Call Highlights Growth and Expansion - TipRanks
Fennec Pharmaceuticals First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
FENC: Craig-Hallum Raises Price Target for Fennec Pharmaceuticals | FENC Stock News - GuruFocus
Fennec (FENC) Receives Increased Price Target from Craig-Hallum - GuruFocus
Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q1 2025 Earnings Call Transcript - Insider Monkey
Contrasting Fennec Pharmaceuticals (NASDAQ:FENC) and VectivBio (NASDAQ:VECT) - Defense World
Fennec Pharmaceuticals Reports Strong Q1 2025 Growth - TipRanks
Fennec Pharmaceuticals Q1 2025 Earnings Call Transcript - MarketBeat
Fennec Pharmaceuticals Q1 Product Sales USD 8.8 Million - marketscreener.com
FENC Reports Strong Q1 Revenue Surpassing Expectations | FENC St - GuruFocus
Fennec Pharmaceuticals Sees Revenue Surge with Strategic Expansion in Europe - TipRanks
FENNEC PHARMACEUTICALS Earnings Results: $FENC Reports Quarterly Earnings - Nasdaq
Fennec Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update - The Manila Times
Fennec Pharmaceuticals Brief: Q1 Basic and Diluted Loss Per Common Share US$0.04 - marketscreener.com
Barclays PLC Grows Stock Position in Fennec Pharmaceuticals Inc (NASDAQ:FENC) - Defense World
Wells Fargo & Company MN Has $83,000 Position in Fennec Pharmaceuticals Inc (NASDAQ:FENC) - Defense World
Fennec Pharmaceuticals (FENC) Expected to Announce Quarterly Earnings on Tuesday - Defense World
Fennec Pharmaceuticals to Report First Quarter 2025 Financial Results on May 13, 2025 - The Manila Times
When (FENC) Moves Investors should Listen - news.stocktradersdaily.com
Recent uptick might appease Fennec Pharmaceuticals Inc. (NASDAQ:FENC) hedge funds owners after losing 32% over the past year - Yahoo Finance
Geode Capital Management LLC Raises Position in Fennec Pharmaceuticals Inc (NASDAQ:FENC) - Defense World
Fennec Pharmaceuticals Inc.'s (NASDAQ:FENC) Share Price Is Matching Sentiment Around Its Revenues - simplywall.st
Where are the Opportunities in (FENC) - news.stocktradersdaily.com
Fennec Pharmaceuticals: Top 10 Undervalued Biotechnology Industry Stocks (FRX) - The Globe and Mail
Fennec Pharmaceuticals Inc (FENC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.06%
0.26%
자본화:
|
볼륨(24시간):